Kim, Hyung-Don
Ryu, Min-Hee
Park, Young Soo
Lee, Sun Young
Moon, Meesun
Kang, Yoon-Koo http://orcid.org/0000-0003-0783-6583
Article History
Received: 21 May 2021
Accepted: 11 August 2021
First Online: 1 September 2021
Declarations
:
: Nothing directly related to this work. Outside of this work, YKK has served as a consultant for ALX Oncology, Zymeworks, Amgen, Novartis, Macrogenics, Daehwa, Blueprint, Surface Oncolgy, BMS, and Merck (MSD).
Free to read: This content has been made available to all.